Gabriele Aquilina | Biomedscis Editor

Biomedscis Honorable Editors

Name: Gabriele Aquilina
Department: National Centre for Chemicals
University: Italian National Institute of Health
Country: Italy

Gabriele Aquilina is a Senior scientist of the Italian National Institute of Health (ISS). The first years of his scientific activity were focused on the experimental analysis of the mutagenic activity of chemicals associated with environmental and/or professional exposure in different test systems, mainly in vitro. In the following period he worked on DNA damage and repair, in particular investigating the DNA Mismatch Repair system and its role in the processing of exogenous DNA lesions produced by genotoxic agents. Since 2009 he was appointed as expert of genetic toxicology in international committees for risk assessment; in particular he was member of the Expert panel on feed additives of the European Food Safety Authority (EFSA) for three consecutive mandates. He is currently member of the Expert panel on Food additives and flavourings of EFSA and of the Committee for Risk Assessment of the European Chemicals Agency (ECHA). Since 2010 he is the Head of the Italian delegation to the Joint Meeting of the Environment, Health and Safety Programme of OECD and Italian National coordinator of the OECD Test Guideline Programme.

DNA damage and repair; Genetic toxicology; Mutagenesis and carcinogenesis

To Know More About Open Access Journal of Biomedical Science Please Visit: Biomedscis
Are Click on:  https://biomedscis.com

Comments

Post a Comment

Popular posts from this blog

Review on Analysis of Breast Tumor with Methods of Treatment: OAJBS Publishers

Image
Review on Analysis of Breast Tumor with Methods of Treatment by Nagham Mahmood Aljamali* in Open Access Journal of Biomedical Science (OAJBS) Breast malignance is the greatest public in ladies, with a high incidence in North America and Eastern Europe, medium in Southern Europe and the Middle East and low in the Far East. Breast malignance is the second most common malignance in the world after lung malignance, and since it happens a lot, the doctors asked the women to examine themselves by themselves, in order to discover the signs of the disease early before it spreads. It is possible that this disease can be treated after being diagnosed by a specialized doctor and determining the type of tumor in the breast, and the surgeon removes the breast completely and starts chemotherapy about 6 doses, then radiotherapy, how many sessions will be determined by the doctor, and then hormonal therapy, a medicine called Tamoxafin or any medicine determined by the doctor, and it is possible. This
Read more

Facile Synthesis of Chitosan Nanoparticle with Different Features and Histopathological Ultrastructural Study on The Effect of Its Bio-complex with Bovine Serum Albumin: OAJBS Publishers

Image
Facile Synthesis of Chitosan Nanoparticle with Different Features and Histopathological Ultrastructural Study on The Effect of Its Bio-complex with Bovine Serum Albumin in Mice Liver by Maged El-Kemary* in Open Access Journal of Biomedical Science (OAJBS)   We have synthesized chitosan nanoparticles (CS-NPs) with different characteristics using ionic gelation method. Results showed that the synthesized CS-NPs with different concentrations of trisodium polyphosphate (TPP) are irregular – spherical shaped with narrow size distribution and high stability. The microporous chitosan was also synthesized with new features characterized with different techniques as SEM, EDX, FTIR and BET. The synthesized microporous chitosan has a surface area and pore volume of 245.571m 2 /g and 0.155cm 3 /g respectively. Its microporous surface is functionalized with carboxyl and amine groups. Histopathological and ultrastructural studies of mice liver were performed using optical and scanning electron micro
Read more

Assessment of Medication Errors in Emergency Ward at Nekemte Referral Hospital, West Ethiopia: OAJBS Publishers

Image
Assessment of Medication Errors in Emergency Ward at Nekemte Referral Hospital, West Ethiopia by Balisa Mosisa* in Open Access Journal of Biomedical Science (OAJBS) Medication error is defined as failure in the treatment process that leads to or has the potential to lead to harm to the patient. It may occur at each five stages of drug ordering and delivery including prescription, transcription, dispensing, and administration or monitoring. Prevalence of medication error in healthcare settings have been found that they were common in hospitals. A significant proportion of medication errors are associated with actual or potentially harmful effects. https://biomedscis.com/fulltext/assessment-of-medication-errors-in-emergency-ward-at-nekemte-referral-hospital-west-ethiopia.ID.000398.php To Know More About Open Access Journal of Biomedical Science Please Visit: Biomedscis Are Click on:   https://Biomedscis.Com/
Read more